You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 196071 - 196080 of 205043 results
  1. TEXT4DIET

    SBC: SANTECH, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): With the obesity epidemic permeating all segments of society, novel weight loss tools with broad appeal and reach are essential. The pervasive use of personal mobile phones in the U.S. provides a unique opportunity to promote positive behavior change through timely and tailored health messages. We propose to develop a mobile phone based application, Text4Diet , ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Anti-HTRA1 Therapy For AMD

    SBC: NAVIGEN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In our Phase I application, we proposed that blocking HTRA1 with antibodies might be an effective strategy for treating age related macular degeneration. We tested this hypothesis by a) generating monoclonal antibodies against HTRA1 and b) determining whether a monoclonal antibody would be effective in models of vascular eye disease. We have accomplished each o ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  3. PHOSPHORYLATABLE MONOCLONAL ANTIBODIES FOR TUMOR THERAPY

    SBC: Pbl Biomedical Laboratories            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term objectives of this proposal are to develop an efficient, effective, safe, convenient and economical monoclonal antibodies (MAbs) labeled with radioactive phosphate for therapy of cancers. Many chemical labeling procedures are currently used, but all these methods inactivate the antibodies to a significant extent (20 - 70 percent). The technology d ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  4. Reduced gluten cereal grains

    SBC: Arcadia Biosciences, Inc.            Topic: 300

    DESCRIPTION provided by applicant Celiac disease CD is the most common food sensitive enteropathy known affecting approximately of the population and its incidence appears to be on the rise In addition non celiac gluten sensitivity GS has recently been revealed to be a distinct condition that affects a growing number of individuals Both of these conditions are triggered by gluten a ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. Improvement and validation of the Spring System for Permanent Relief of Urinary Obstruction related to Benign Prostatic Hyperplasia (BPH)

    SBC: ZENFLOW, INC.            Topic: 400

    ABSTRACT Benign Prostatic Hyperplasia (BPH) is the most common cause of obstructive lower urinary tract symptoms in men. As the prostate progressively enlarges with age, it obstructs the flow of urine from the bladder, leading to urinary straining, frequency, urgency, and nocturia. At Zenflow, we have developed the Spring System, which consists of a single-wire nickel titanium (nitinol) coil impla ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  6. Integrated In Vitro and Alternative Ocular IIVAO Irritation Testing Strategy

    SBC: MB RESEARCH LABORATORIES, INC.            Topic: N

    DESCRIPTION provided by applicant Ocular irritation testing is extremely relevant to assuring adequate safety levels of public health as new formulations of chemicals and products are introduced In most cases these safety assessments are performed using the Draize Rabbit Eye test resulting in thousands of rabbits used in testing every year Alternatives have been discussed since the s with ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Development and Commercialization of a pupillometer to predict postoperative opioid-induced respiratory depression in children

    SBC: Neuroptics, Inc.            Topic: NIDA

    PROJECT SUMMARY With about 50 million surgeries performed annually in the US. Opioids are commonly used as primary analgesics to control severe surgical pain. However, opioids are associated with several adverse effects including nausea, vomiting, sedation, and more serious respiratory depression and death. Respiratory depression is recognized as one of the most serious, life threatening and costl ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Online Training and Automated Documentation for Administering Meds in Schools

    SBC: MCCARTHY MEDICAL MARKETING, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The primary goal of the school nurse is to assure the health and safety of the students in the school(s) she/he oversees. This includes assuring that medications are administered to schoolchildren correctly. New data indicate that about 35% of school nurses are responsible daily for over 5,000 students. Approximately 20 million children attending public schools ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  9. Use of Time Series Biomarker and Clinical Data to Construct a Time Trajectory Host Response Map

    SBC: PRENOSIS INC            Topic: 300

    Principal Investigator/Program Director (Last, first, middle): Reddy, Jr., Bobby Project Summary: Sepsis is an incompletely understood clinical syndrome characterized by a dysregulated host response to infection. In partnership with 8 U.S. hospitals, Prenosis amassed one of the world’s largest datasets and biobanks that combines biomarker and clinical data for patients suspected of infection, ho ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Infection resistant surface for ventricular assist device (VAD) transcutaneous dr

    SBC: ENSION Inc            Topic: NHLBI

    DESCRIPTION (provided by applicant): Infection is a common and frequently very serious complication associated with medical implants. Man-made materials, including those used to fabricate ventricular assist devices (VADs), compromise the body's ability tofight infection in tw ways. First, by breaching skin with transcutaneous cannulae and drivelines, and second, by eliciting a foreign body re ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government